MedPath

Green Light Exposure in Healthy Volunteers Exposure in Normal Human Volunteers

Not Applicable
Active, not recruiting
Conditions
Chronic Pain
Interventions
Device: White Light Emitting Diode
Device: Green Light Emitting Diode
Registration Number
NCT05295225
Lead Sponsor
University of Arizona
Brief Summary

This research project is intended to understand the mechanisms of action for the pain-relieving properties of visual green light exposure.

The investigators have shown previously that greenlight exposure decreased acute and chronic pain in both animals and humans. However, the investigators do not yet understand how green light exposure is capable of such function.

Detailed Description

Pain is a biological function. There are several pain centers in the brain that modulate the intensity of the pain signal perceived by the brain. Part of the modulations takes place through two separate pathways. The first pathway mediates pain signals and is known as the ascending facilitator pain pathway. The main function of this pathway is to relay the pain signal to the brain to be processed.

The second pathway is known as the descending inhibitory pain pathway. The main function of this pathway is to inhibit the pain signal mediated by the first pathway.

Normal humans typically have a balance between the activities of the ascending and descending pain pathways.

The investigator animal studies suggest that green light therapy exhibits its pain-relieving effects through altering the balance between the ascending and descending pain pathway in a manner to result in an overall reduction or normalization in pain perception.

To test this hypothesis, the investigators propose recruiting 30 healthy human volunteers. The participants will be equally randomized into either green light (treatment) or white light (control) exposure groups. The investigators will initially test the activities of the ascending and descending pathways using thermal and mechanical stimulations. The investigators will also test brain wave activities using a non-invasive EEG device. After establishing the baseline activities of the pain pathways and brain waves, the volunteers will be exposed to the green light or white light at low intensity (4-100 lux) for two hours in our laboratory. After two hours of light exposure, the investigators will again test the activities of the pain pathways using thermal and mechanical stimulation and measure the brain wave EEG activities.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. 18-50 years healthy men or women
  2. Able to speak and understand English
  3. No history of Chronic pain
  4. No known neuropathies in areas that testing will take place, (forearms, muscle at the base of thumb on the palm of the hand and upper back/shoulder area.
Exclusion Criteria
  1. Serious mental illness defined as distortions of perception, delusions, hallucinations, and unusual behaviors resulting in loss of contact with reality. This will be assessed during the screening interview.
  2. Colorblindness or uncorrected cataracts.
  3. Tissue damage in areas that testing will take place, (forearms, muscle at the base of the thumb on the palm of the hand, and upper back/should area.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
White Light ExposureWhite Light Emitting DiodeSubjects will complete thermal and mechanical pain threshold detection tests and Electroencephalography (EEG). After completion, subjects will be exposed to a white light-emitting diode for two hours. After exposure, thermal and mechanical pain threshold assessments and Electroencephalography (EEG) will be conducted.
Green Light ExposureGreen Light Emitting DiodeSubjects will complete thermal and mechanical pain threshold detection tests and Electroencephalography (EEG). After completion, subjects will be exposed to a green light-emitting diode for two hours. After exposure, thermal and mechanical pain threshold assessments and Electroencephalography (EEG) will be conducted.
Primary Outcome Measures
NameTimeMethod
Ascending Pain PathwayTwo hours

Changes in activity of the ascending pain pathway

Descending Pain PathwayTwo hours

Changes in activity of the descending pain pathway

Secondary Outcome Measures
NameTimeMethod
Delta Brain ActivitiesTwo hours

Changes in the baseline of Delta waves of EEG

Theta Brain ActivitiesTwo hours

Changes in the baseline of Theta waves of EEG

Alpha Brain ActivitiesTwo hours

Changes in the baseline of Alpha waves of EEG

Beta Brain ActivitiesTwo hours

Changes in the baseline of Beta waves of EEG

Sigma Brain ActivitiesTwo hours

Changes in the baseline of Sigma waves of EEG

Trial Locations

Locations (1)

Banner University Medical Center Tucson

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath